You are here » Home » Companies » Company Overview » Everest Organics Ltd

Everest Organics Ltd.

BSE: 524790 Sector: Health care
NSE: N.A. ISIN Code: INE334C01029
BSE 00:00 | 18 Jun 101.10 1.20
(1.20%)
OPEN

94.00

HIGH

104.50

LOW

90.00

NSE 05:30 | 01 Jan Everest Organics Ltd
OPEN 94.00
PREVIOUS CLOSE 99.90
VOLUME 167
52-Week high 183.65
52-Week low 84.50
P/E 47.24
Mkt Cap.(Rs cr) 81
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 94.00
CLOSE 99.90
VOLUME 167
52-Week high 183.65
52-Week low 84.50
P/E 47.24
Mkt Cap.(Rs cr) 81
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Everest Organics Ltd. (EVERESTORGANICS) - Company History

Everest Organics was incorporated at Hyderabad in Feb.'93. It was promoted by S K Srihari Raju and S K Chittiramabhadra Raju. The company set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project. Commercial production of ciprofloxacin and omerprazole commenced in Feb.'96. The company preferred to manufacture para hydroxy phynyl glycin (PHPG), but due to market conditions, it decided to drop manufacturing of PHPG and has decided to enhance the capacity of ciprofloxacin from 30 tpa to 120 tpa and also to manufacture enrofloxacin/naproxen. The company has increased its installed capacity of Benzimidazole by 60 tpa there by taking its capacity to 120 tpa.The installed capacity of Omeprazole Op Sulphide was increased from 15 TPA to 30 TPA.